SBIR-STTR Award

Non-destructive evaluation of drugs and biomaterials
Award last edited on: 4/30/02

Sponsored Program
SBIR
Awarding Agency
NIH : NIGMS
Total Award Amount
$50,000
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Philip Brown

Company Information

Tronac Inc

651 South 100 West
Orem , UT 84058
   (801) 224-1131
   N/A
   N/A
Location: Single
Congr. District: 03
County: Utah

Phase I

Contract Number: 1R43GM038398-01
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1987
Phase I Amount
$50,000
The objective of this research is to develop a nondestructive technique based on microwatt batch calorimetry to study the degradation of drugs (solid-state and liquid formulations), biochemicals, and biomaterials (e.g., those used in artificial organs). As a research tool, the microwatt calorimeter is complementary to, and provides information unattainable by, more specific methods such as chromatography and spectrophotometry.The aim of Phase I is to establish the feasibility of using a microwatt calorimeter to study the degradation of solid-state dosage forms of drugs and drug mixtures. The effect of alternative heat sink materials and sample chamber configurations on instrument equilibration, sensitivity, and accuracy will also be investigated. In Phase II, an instrument will be designed based on Phase I results. The new instrument will have sophisticated electronic control and will be used to study a wide range of drugs, biochemicals, and biomaterials.The successful completion of this investigation will provide researchers with a rapid, accurate, and reliable instrument to measure overall decomposition rates without applying a physical or chemical stress (e.g., dissolution, heating, changes in ionic strength, etc.). Thus, new insights into the degradation process will be achieved.

Thesaurus Terms:
Biomaterials, Biomaterials Evaluation, Biomedical Engineering, Medical Equipment Safety, Drug Quality-Standards, Temperature, Heat, Calorimetry Biomedical Engineering, Technology Development, Drugs, Pharmacology National Institute of General Medical Sciences (NIGMS)

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----